About Aarhus University
Jørgen Frøkiær
Renal potassium excretion visualized on 82Rubidium PET/CT
Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Links
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198679/pdf/13139_2020_Article_637.pdf
Final published version
DOI
- https://doi.org/10.1007/s13139-020-00637-8
Final published version
The positron emission tomography (PET) flow tracer 82Rubidium is a known potassium analogue. During our studies of tumor blood flow in prostate cancer, we found that approximately 10% of the patients had high urinary 82Rubidium activity. In roughly half of these patients, the increased renal rubidium/potassium excretion was either causing hypokalemia or explained by Thiazide treatment. In the other half, there was no obvious explanation or clinical consequence of the renal rubidium/potassium excretion. This is the first time enhanced renal potassium excretion is visualized on 82Rubidium PET/CT.
| Original language | English |
|---|---|
| Journal | Nuclear Medicine and Molecular Imaging |
| Volume | 54 |
| Issue | 2 |
| Pages (from-to) | 120-122 |
| Number of pages | 3 |
| ISSN | 1869-3474 |
| DOIs | |
| Publication status | Published - Apr 2020 |
- Hypokalemia, PET, Potassium, Prostate cancer, Renal excretion, Rubidium
Research areas
See relations at Aarhus University Citationformats
Projects
ID: 182440496